EUVIMEDEUVIMED entdecken
Fallbericht

Transplantation of a genetically modified porcine heart into a live human

Bartley P Griffith, Alison Grazioli, Avneesh K Singh, Andy Tully, Javier Galindo, Kapil K Saharia, Aakash Shah, Erik R Strauss, Patrick N Odonkor, Brittney Williams, Henry J Silverman, Allen Burke und 25 weitere

Nature Medicine · 2025-02 · 31 (2) · 589-598

DOI: 10.1038/s41591-024-03429-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nature Medicine, online erschienen am 08.01.2025. Verfasst von Bartley P Griffith und 36 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery, University of Maryland School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Heart Transplantation, Heart Failure. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NIAID NIH HHS, U.S. Department of Health & Human Services | National Institutes of Health (NIH), United Therapeutics Corporation (United Therapeutics).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following our previous experience with cardiac xenotransplantation of a genetically modified porcine heart into a live human, we sought to achieve improved results by selecting a healthier recipient and through more sensitive donor screening for potential zoonotic pathogens. Here we transplanted a 10-gene-edited pig heart into a 58-year-old man with progressive, debilitating inotrope-dependent heart failure due to ischemic cardiomyopathy who was not a candidate for standard advanced heart failure therapies. He was maintained on a costimulation (anti-CD40L, Tegoprubart) blockade-based immunomodulatory regimen. The xenograft initially functioned well, with excellent systolic and diastolic function during the first several weeks posttransplantation. Subsequently, the xenograft developed rapidly progressing diastolic heart failure, biventricular wall thickening and, ultimately, near-complete loss of systolic function necessitating initiation of extracorporeal membranous oxygenation on day 31. Given these setbacks, the patient chose to transition to comfort care after 40 days. As with our first patient, histology did not reveal substantial immune cell infiltration but suggested capillary endothelial injury with interstitial edema and early fibrosis. No evidence of porcine cytomegalovirus replication in the xenograft was observed. Strategies to overcome the obstacle of antibody-mediated rejection are needed to advance the field of xenotransplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousHeart TransplantationHeart FailureAnimalsHumansMaleMiddle AgedSwineAnimals, Genetically ModifiedGraft RejectionHeterografts

Autor:innen und Institutionen

  • Cardiothoracic Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
  • University of Maryland School of Medicine, Baltimore, MD, USA.
  • Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • MedStar Heart & Vascular Institute, Columbia, MD, USA.

Förderung

  • NIAID NIH HHS
  • U.S. Department of Health & Human Services | National Institutes of Health (NIH)
  • United Therapeutics Corporation (United Therapeutics)

Zitieren

APA

Griffith, B. P., Grazioli, A., Singh, A. K., Tully, A., Galindo, J., Saharia, K. K., Shah, A., Strauss, E. R., Odonkor, P. N., Williams, B., Silverman, H. J., Burke, A., Drachenberg, C. B., Wells, C. L., Dickfeld, T., Hong, S. N., Hicks, A. J., Ananthram, M., Gupta, A., …, & Mohiuddin, M. M. (2025). Transplantation of a genetically modified porcine heart into a live human. Nature Medicine, 31(2), 589-598. https://doi.org/10.1038/s41591-024-03429-1

Vancouver

Griffith BP, Grazioli A, Singh AK, Tully A, Galindo J, Saharia KK, et al. Transplantation of a genetically modified porcine heart into a live human. Nature Medicine. 2025;31(2):589-598. doi:10.1038/s41591-024-03429-1

BibTeX
@article{Griffith2025,
  author = {Griffith, Bartley P and Grazioli, Alison and Singh, Avneesh K and Tully, Andy and Galindo, Javier and Saharia, Kapil K and Shah, Aakash and Strauss, Erik R and Odonkor, Patrick N and Williams, Brittney and Silverman, Henry J and Burke, Allen and Drachenberg, Cinthia B and Wells, Chris L and Dickfeld, Timm and Hong, Susie N and Hicks, Albert J and Ananthram, Manjula and Gupta, Anuj and Christenson, Robert H and Tamburro, Lo and Zhang, Tianshu and Hershfeld, Alena and Lewis, Billeta and Feller, Erika D and Kuravi, Kasinath and Sorrells, Lori and Morgand, Erwan and Mezine, Fariza and Goutaudier, Valentin and Rothblatt, Martine and Lau, Christine L and Taylor, Bradley and Perrin, Steve and Loupy, Alexandre and Ayares, David and Mohiuddin, Muhammad M},
  title = {Transplantation of a genetically modified porcine heart into a live human},
  journal = {Nature Medicine},
  year = {2025},
  volume = {31},
  number = {2},
  pages = {589--598},
  doi = {10.1038/s41591-024-03429-1}
}
Kostenlos starten →